World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01016613
Date of registration: 18/11/2009
Primary sponsor: University of Michigan
Public title: Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center C-PROBE
Scientific title: Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
Date of first enrolment: January 2009
Target sample size: 1500
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01016613
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Countries of recruitment
United States
Contacts
Name:   Frank C Brosius, MD
Address: 
Telephone:
Email:
Affiliation:  University of Michigan
Name:   Crystal A Gadegbeku, MD
Address: 
Telephone:
Email:
Affiliation:  University of Michigan Health System
Name:   Matthias Kretzler, MD
Address: 
Telephone:
Email:
Affiliation:  University of Michigan Health System
Key inclusion & exclusion criteria

Inclusion Criteria:

- persons of any age who have chronic kidney disease (abnormally high protein in urine
or reduced kidney function determined by blood tests)

- a small number of people without chronic kidney disease

Exclusion Criteria:

- people on hemodialysis or peritoneal dialysis

- people who have had a kidney transplant

- people unable or unwilling to provide consent

- women who are pregnant or nursing

- people who have polycystic kidney disease

- people with a hemoglobin of <9 at the time of enrollment

- institutionalized persons

- people currently participating in a blinded interventional clinical trial



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Chronic Kidney Disease
Glomerulopathy
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
P30 DK 081943
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
St. John Health System, Michigan
University of Illinois
Wayne State University
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history